JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sievenpiper, J. L.
Right arrow Articles by Vuksan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sievenpiper, J. L.
Right arrow Articles by Vuksan, V.
Journal of the American College of Nutrition, Vol. 22, No. 6, 524-532 (2003)
Published by the American College of Nutrition


Original Research

Null and Opposing Effects of Asian Ginseng (Panax ginseng C.A. Meyer) on Acute Glycemia: Results of Two Acute Dose Escalation Studies

John L. Sievenpiper, MSc, John T. Arnason, PhD, Lawrence A. Leiter, MD and Vladimir Vuksan, PhD

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital (J.L.S., L.A.L., V.V.), Toronto, CANADA
Department of Biology, Faculty of Science, University of Ottawa, Ottawa (J.T.A.), CANADA

Address reprint requests to: Vladimir Vuksan, PhD, Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, #6 138-61 Queen Street East, Toronto, Ontario, M5C 2T2, CANADA. E-mail: v.vuksan{at}utoronto.ca

Objective: We have repeatedly reported that a batch of American ginseng with a specific ginsenoside (glycosidal saponin) profile decreases acute postprandial glycemia. We investigated whether Asian ginseng is able to replicate this glycemia-lowering efficacy in two separate acute dose escalation studies.

Methods: Each study was conducted in a separate sample of 11 healthy subjects (gender:8M:3F and 6M:5F, age: 29 ± 2y and 27 ± 3y, BMI: 28.5 ± 2.1 kg/m2 and 26.9 ± 1.4 kg/m2) using a randomized, single-blind, placebo-controlled, multiple-crossover design. Treatments consisted of 0 (placebo), 1, 2, and 3 g of Asian ginseng for the first study and 0 (placebo), 3, 6, and 9 g Asian ginseng for the second study administered 40 minutes before a 75g-OGTT protocol with blood drawn at -40, 0, 15, 30, 45, 60, 90, and 120 minutes. Ginsenosides were analyzed by HPLC-UV.

Results: Neither the main effect of pooled-treatment, nor dose, nor either factors interaction with time was significant for incremental plasma glucose and insulin. But the diagnostically and therapeutically relevant two-hour plasma glucose (2h-PG) value was significantly higher for pooled Asian ginseng treatment than placebo (5.46 ± 0.31 versus 4.99 ± 0.30 mmol/L, p = 0.050). Ginsenoside analyses showed that the Asian ginseng contained up to 96% lower and sevenfold higher quantities of various ginsenosides and their ratios than our previous efficacious batch of American ginseng.

Conclusions: Asian ginseng showed both null and opposing effects on indices of acute postprandial plasma glucose and insulin. This is in contrast to our findings with American ginseng. One explanation may be the marked ginsenoside differences. Practitioners and consumers should be aware of ginseng’s variable effects.

Key words: complementary and alternative medicine, ginseng, postprandial, glucose, insulin




This article has been cited by other articles:


Home page
PediatricsHome page
S. Vohra, B. C. Johnston, K. L. Laycock, W. K. Midodzi, I. Dhunnoo, E. Harris, and L. Baydala
Safety and Tolerability of North American Ginseng Extract in the Treatment of Pediatric Upper Respiratory Tract Infection: A Phase II Randomized, Controlled Trial of 2 Dosing Schedules
Pediatrics, August 1, 2008; 122(2): e402 - e410.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. L. Sievenpiper, M.-K. Sung, M. Di Buono, K. Seung-Lee, K. Y. Nam, J. T. Arnason, L. A. Leiter, and V. Vuksan
Korean Red Ginseng Rootlets Decrease Acute Postprandial Glycemia: Results from Sequential Preparation- and Dose-Finding Studies.
J. Am. Coll. Nutr., April 1, 2006; 25(2): 100 - 107.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. Buettner, G. Y Yeh, R. S Phillips, M. A Mittleman, and T. J Kaptchuk
Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors
Ann. Pharmacother., January 1, 2006; 40(1): 83 - 95.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. Stavro, M. Woo, T. F. Heim, L. A. Leiter, and V. Vuksan
North American Ginseng Exerts a Neutral Effect on Blood Pressure in Individuals With Hypertension
Hypertension, August 1, 2005; 46(2): 406 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. L. Sievenpiper, J. T. Arnason, L. A. Leiter, and V. Vuksan
Decreasing, Null and Increasing Effects of Eight Popular Types of Ginseng on Acute Postprandial Glycemic Indices in Healthy Humans: The Role of Ginsenosides
J. Am. Coll. Nutr., June 1, 2004; 23(3): 248 - 258.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. L. Sievenpiper, J. T. Arnason, E. Vidgen, L. A. Leiter, and V. Vuksan
A Systematic Quantitative Analysis of the Literature of the High Variability in Ginseng (Panax spp.): Should ginseng be trusted in diabetes?
Diabetes Care, March 1, 2004; 27(3): 839 - 840.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Nutrition.